Skip to main content
No.1 Press Release Service in Korea
Search
Search
Login
Create Account
Services
Contact Us
News
Services
About Us
Contact Us
Korean
News
All News
News by Region
Korea
Overseas
News by Industry
Health
Economy
Education
Finance
Technology
Life Style
Leisure
Culture & Entertainment
Transportation
Society
Heavy Industries
Environment
Government
Services
Why Korea Newswire?
How We Distribute
Services & Pricing
Basic
Standard
Premium
Global
Translation
Press Release Network in Korea
Korean Language
About Us
News
Services
Contact Us
Search
Cancel
Search
Submit Press Release
Latest News
News by Region
Korea
World
News by Industry
Health
Economy
Education
Finance
Technology
Life Style
Leisure
Culture & Entertainment
Transportation
Society
Heavy Industries
Environment
Government
Health News Releases
Today May 22
September 20, 2024 17:00
Neuraptive Therapeutics Announces Presentation of Phase 2 Topline Interim Results for NTX-001 at the 2024 American Society for Surgery of the Hand (ASSH) Annual Meeting
Neuraptive Therapeutics Inc., a leading biopharmaceutical company focused on novel treatments for peripheral nerve injuries, today announced that interim topline results from its ongoing Phase 2 NEURO
September 20, 2024 14:20
Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%
Organon (NYSE: OGN), a global healthcare company with a mission to improve the health of women throughout their lives, and Dermavant Sciences Ltd. announced today that they have entered into a definit
September 20, 2024 09:49
Takeda to Present Additional Clinical Trial Study Data Highlighting the Impact of Orexin Agonist TAK-861 on the Burden of Narcolepsy at Sleep Europe 2024
Takeda (TSE:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2F&esheet=54124174&newsitemid=20240919392083&lan=en-US&anchor=TSE%3A4502%2FNYSE%
September 20, 2024 09:45
Takeda Commits Over $32 Million in Five New Global Corporate Social Responsibility Partnerships to Further Drive Health Impact in 93 Countries
Takeda (TOKYO:4502/NYSE: TAK) today committed JPY4.6 billion (Approx. USD 32 million) to five new Global Corporate Social Responsibility (CSR) partners as part of the company’s ongoing commitment to i
September 19, 2024 14:35
Medidata Recognized as a Leader in Everest Group’s Inaugural Electronic Data Capture PEAK Matrix® Assessment
Medidata, a Dassault Systèmes brand and the leading provider of clinical trial solutions to the life sciences industry, has been recognized as a Leader in Everest Group's first-ever PEAK Matrix® Asses
September 18, 2024 15:15
Viromed Medical AG Plans to Acquire All Shares of ActivCell Group AG by Way of a Capital Increase Against Contribution in Kind with Exclusion of Subscription Rights
Viromed Medical AG (Ticker: VMED (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Feqs-cockpit.com%2Fcgi-bin%2Ffncls.ssp%3Ffn%3Dredirect%26url%3D03003d462bf07ae5fbd5a9dd7d755919%26app
September 18, 2024 13:55
Kaitie Kramer Joins Parse Biosciences as Vice President of Marketing
Parse Biosciences (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.parsebiosciences.com%2F&esheet=54122668&newsitemid=20240917957215&lan=en-US&anchor=Parse+Biosciences&index=1&md
September 18, 2024 12:10
Vectura Fertin Pharma, Inc., a Subsidiary of Philip Morris International, Announces Agreement for Sale of Vectura Group to Molex
Vectura Fertin Pharma, Inc., an affiliate of Philip Morris International Inc. (PMI) (NYSE: PM), today announces the sale of its subsidiary Vectura Group Ltd. (Vectura) to Molex Asia Holdings Ltd., and
September 18, 2024 11:45
Galderma Reaffirms Its Leadership in Dermatology With Extensive Presence at EADV 2024
Galderma (SWX:GALD), the pure-play dermatology category leader, announced today it will be showcasing updates from across its industry-leading dermatology portfolio at the 33rd European Academy of Der
September 18, 2024 09:45
Transforming the Future of Medicine with RNA-Based Therapies
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, ha
September 13, 2024 15:35
MicroVention Rebrands to Terumo Neuro - Reflects Expanded Focus and Strategic Growth
MicroVention, Inc., a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today announced its official rebranding to Terumo Neuro, effective immediately. Thi
September 13, 2024 14:30
ITM Obtains Exclusive Worldwide License from Debiopharm for CA IX-Targeted Peptide-based Radiopharmaceutical Programs Targeting Solid Tumors
ITM Isotope Technologies Munich SE (ITM) (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.globenewswire.com%2FTracker%3Fdata%3DknxVWFX97-AJVcLZDmqPUgpwJEhTXICkW7WWecPUpZ99eWRx-Db
September 13, 2024 13:40
Neuraptive Therapeutics Receives FDA Breakthrough Therapy Designation for NTX-001 and Provides Update on the Advancements of NTX-001 for the Treatment of Peripheral Nerve Injury Requiring Repair
Neuraptive Therapeutics, Inc. today announced that NTX-001 has been granted Breakthrough Therapy Designation, thus providing the potential for accelerated development for patients with peripheral nerv
September 13, 2024 11:50
Novotech Unveils 2024 Report on Global Gastric Cancer Clinical Trials and Cutting-Edge Therapeutics
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, ha
September 13, 2024 09:55
Novotech Wins Prestigious Brandon Hall Gold Award for CRA Monitoring Simulation Program under the category of Best Competencies and Skill Development
Novotech, a leading full-service clinical Contract Research Organization (CRO), is proud to announce that its Clinical Research Associate (CRA) Monitoring Simulation Program has been recognized with t
September 13, 2024 08:55
Merck Unveils New MAVENCLAD® Four-Year Data Highlighting Benefits of Early Treatment and Sustained Efficacy Across Multiple Measures of Disease Activity
Not intended for UK-, US- or Canada-based media Merck, a leading science and technology company, today announced presentations showcasing the long-term safety profile, sustained efficacy data, and
September 12, 2024 13:50
Novotech Appoints Dr. Yooni Kim as a New Executive Position of Managing Director for APAC to Strengthen Global Expansion
Novotech, the leading global biotech Contract Research Organization (CRO), is pleased to announce the appointment of Dr. Yooni Kim as a new Executive position of Managing Director for the Asia-Pacific
September 11, 2024 17:20
Novotech Honored with Frost & Sullivan’s 2024 Best Practices Company of the Year Award for Leadership in Biotech CRO Services
Novotech, the global full-service clinical Contract Research Organization (CRO), is proud to announce that it has been awarded the prestigious 2024 Global Company of the Year Award by Frost & Sullivan
September 11, 2024 11:05
CorFlow Therapeutics AG Completes €44 Million Series B Financing to Support the Advancement of a Novel Diagnostic and Drug Delivery Platform for Microvascular Obstruction (MVO) in Heart Attack Patients
CorFlow Therapeutics AG (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.corflow.com&esheet=54114953&newsitemid=20240910783655&lan=en-US&anchor=CorFlow+Therapeutics+AG&index=1&md5
September 11, 2024 09:40
Saint-Denis Hospital Center in France Implements Masimo SafetyNet® Telemonitoring to Facilitate Early Discharge of Premature Newborns from the Hospital
Masimo (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.masimo.com&esheet=54118830&newsitemid=20240908136612&lan=en-US&anchor=Masimo&index=1&md5=34c96fb7c39ca290fc395f6f1f3b2eb9)
September 10, 2024 16:11
MRM Health Appoints Grégoire Franoux as Chief Business Officer and Adds Ron Robison to its Board of Directors
MRM Health NV, a clinical-stage biopharmaceutical company developing innovative therapeutics for inflammatory, CNS and metabolic diseases, today announced the appointment of Grégoire Franoux, M.B.A.,
September 06, 2024 10:40
Novotech Releases 2024 Report on Pancreatic Cancer Clinical Trials and Drug Development
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, ha
September 05, 2024 14:15
PHC Launches LiCellMo™ Live Cell Metabolic Analyzer for Real-Time Visualization of Cellular Metabolism in Cell and Gene Therapies
PHC Corporation Biomedical Division (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.phchd.com%2Fglobal%2Fphc&esheet=54116517&newsitemid=20240903521355&lan=en-US&anchor=PHC+Corpo
September 05, 2024 11:15
Avania Appoints Recognized CRO and MedTech Industry Leader, Jason Monteleone, as New President and CEO
Avania (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.avaniaclinical.com%2F&esheet=54116875&newsitemid=20240904978746&lan=en-US&anchor=Avania&index=1&md5=42bb77e18075e818ffddfc
September 04, 2024 16:10
HistoSonics® Publishes Results of its Pivotal #HOPE4LIVER Trials
HistoSonics, (www.histosonics.com), the developer and manufacturer of the Edison® Histotripsy System, announced today the publication of the company’s pivotal clinical trials data in Radiology (https:
September 04, 2024 14:35
Rigaku: Novel Electron Density Topography Technology to Reveal Biological Macromolecules’ Properties
Rigaku Corporation, a Rigaku Holdings Group company and global partner for X-ray analysis from Lab to Fab (headquarters: Akishima, Tokyo; president and CEO: Jun Kawakami; “Rigaku”), has developed a te
August 30, 2024 08:39
Merck Announces First Patient Dosed in Phase III Study of Oral Cladribine in Generalized Myasthenia Gravis (gMG)
Not intended for UK-, US- or Canada-based media Merck, a leading science and technology company, today announced the first patient has been dosed in the Phase III MyClad trial (NCT06463587 (https:/
August 29, 2024 15:50
Galderma Successfully Issued an Inaugural CHF 500 Million Bond
Galderma Group AG (SWX:GALD): NOT FOR DISTRIBUTION IN THE UNITED STATES OR IN ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE RESTRICTED BY APPLICABLE LAW OR REGULATION Galderma succe
August 29, 2024 14:15
Novotech Earns Renewed Certification as an Employer of Choice for Gender Equality
Novotech, a global full-service clinical Contract Research Organization (CRO), proudly announces its continued recognition as a Workplace Gender Equality Agency (WGEA) Employer of Choice for Gender Eq
August 29, 2024 14:00
HistoSonics™ Partners with Li Ka Shing Foundation to Launch First Histotripsy Programs in Hong Kong
HistoSonics, (www.histosonics.com), the developer and manufacturer of the Edison™ Histotripsy System, announced today the company’s initial partnership in Asia with Hong Kong University receiving thei
August 28, 2024 16:50
Avantor Triumphs with Three Awards at Korea Biopharma Excellence Awards 2024
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences advanced technologies industries, has secured three prestigious awards at the estee
August 22, 2024 14:05
PCI Pharma Services’ Bedford, New Hampshire Location Successfully Completes International Coalition of Medicines Regulatory Authorities Inspection
PCI Pharma Services (PCI), a leading global contract development and manufacturing organization (CDMO), has successfully completed the International Coalition of Medicines Regulatory Authorities (ICMR
August 21, 2024 14:45
Organon & Lilly Expand Migraine Commercialization Agreement to 11 Additional Markets
Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, announced it has expanded its agreement with Eli Lilly and Company (Lilly) to become the sole distributor and promoter
August 20, 2024 15:55
Guard Medical Announces FDA 510(k) Clearance for Additional Large Sizes of Its Novel NPseal® NPWT Surgical Dressing, Unlocking the Orthopedic Market
Privately-held company Guard Medical Inc. (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.guard-medical.com%2F&esheet=54110779&newsitemid=20240819281623&lan=en-US&anchor=Guard+Me
August 16, 2024 15:40
HistoSonics Announces Oversubscribed $102 Million Series D Financing to Scale Launch of Non-Invasive Histotripsy Platform
HistoSonics (https://histosonics.com/), the manufacturer of the Edison® Histotripsy System and novel histotripsy therapy platforms, announced today the completion of an oversubscribed $102 million Ser
August 15, 2024 10:25
Bio-Gene and Envu Collaborate to Evaluate Flavocide™ for Use in Public and Private Sector Mosquito Management
Bio-Gene Technology Limited (ASX:BGT or ‘Bio-Gene’), an Australian company developing the next generation of novel bio-insecticides, and Envu are evaluating Flavocide™ for use in professional pest man
August 14, 2024 10:40
Freyr Recognized as a Leader in Everest Group PEAK Matrix® 2024
Freyr, a premier global Regulatory solutions and services provider, proudly announces its distinguished placement as a Leader in the esteemed Everest Group Life Sciences Regulatory and Medical Affairs
August 13, 2024 16:19
Galderma Receives U.S. FDA Approval for Nemluvio® (nemolizumab) for Adult Patients Living With Prurigo Nodularis
Galderma today announced that the U.S. Food and Drug Administration (FDA) has approved Nemluvio® (nemolizumab) as a pre-filled pen for subcutaneous injection for the treatment of adults with prurigo n
August 13, 2024 14:53
Brandnew Lab Concludes Successful Symposium for NUVOEN Launch
On August 13, Brandnew Lab (https://brandnewlab.co.kr) announced the successful launch of its highly anticipated clinical-use ampoule line, NUVOEN, at the symposium that took place on July 22 at the B
August 11, 2024 09:45
Morinaga Milk Obtains the Registration of “New Food Ingredient” in China for use of its Probiotic Bifidobacterium infantis M-63 in Infant Foods
Morinaga Milk Industry Co., Ltd. (https://www.morinagamilk.co.jp/english/) (TOKYO:2264), a leading Japanese dairy product company, today announced its proprietary probiotic Bifidobacterium infantis M-
August 09, 2024 15:35
Parse Biosciences Partners with Taiwan-based Prisma Biotech to Extend Reach in Asia
Parse Biosciences (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.parsebiosciences.com%2F&esheet=54104966&newsitemid=20240807623635&lan=en-US&anchor=Parse+Biosciences&index=1&md
August 09, 2024 15:10
Nichi BRITE Beta glucan as an onco-nutrition supplement in pancreatic cancer; Encouraging clinical results reported by Chikamori Hospital, Japan.
Nichi BRITE Beta glucan administration resulted in enhancement of immunity followed by reduction in biomarkers of pancreatic cancer and that of its recurrence in patients undergoing surgical resection
August 09, 2024 15:00
BeiGene Enters Next Phase of Global Growth with Announcement of Second Quarter 2024 Financial Results and Corporate Updates
BeiGene (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.beigene.com%2F&esheet=54105663&newsitemid=20240807337131&lan=en-US&anchor=BeiGene&index=1&md5=66784fdcb48f17570d0bd05940b
August 08, 2024 15:25
Takeda Receives European Commission Approval for ADZYNMA®▼ (Recombinant ADAMTS13) as the First and Only Recombinant ADAMTS13 Replacement Therapy for Congenital Thrombotic Thrombocytopenic Purpura (cTTP)
Takeda (TSE:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Foverview%2F&esheet=54104396&newsitemid=20240806343138&lan=en-US&anchor=TSE%3A4
August 05, 2024 14:39
Galderma to pursue a new scientific partnership with L’Oréal to further advance its category leadership in dermatology
Galderma today announced that it has signed a memorandum of understanding with L’Oréal to work towards a new research and development (R&D) collaboration in the form of a scientific partnership focuse
August 02, 2024 09:40
In-Depth Report on Global Oesophageal Cancer Clinical Trials Now Available
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, ha
August 01, 2024 15:30
Boston Oncology and King Fahd Medical City (KFMC) Partner to Advance Localized Cell & Gene Therapy in Saudi Arabia
In a landmark initiative poised to transform healthcare in the Kingdom of Saudi Arabia, Boston Oncology and King Fahd Medical City (KFMC) have signed a Letter of Intent to collaborate on the localizat
August 01, 2024 14:30
Biocytogen Announces Option and License Agreement with IDEAYA Biosciences for Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC Program
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotech company focusing on the discovery of novel antibody/ADC therapeutics, announced that it has entered into an o
August 01, 2024 14:00
Takeda Announces First Quarter FY2024 Results - Strong Performance by Growth & Launch Products; Advancements in Promising Late-Stage Pipeline
Takeda (TOKYO:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Fstock-information%2F&esheet=54099945&newsitemid=20240725145481&lan=en-US&anc
July 31, 2024 11:40
Carestream Wins Renowned Award for Dental Films
We’re excited to announce Carestream recently received the Health Leaders Award in the Dental Category from Grupo Mídia in Brazil, a renowned international multimedia company. This distinguished aw
«
4
5
6
7
8
»
50 per page
25 per page
50 per page
75 per page
100 per page
Distribute Your News to
KOREA
The largest press release distribution network in Korea
34,000 journalists
7,000 media outlets
345 industry channel
80,000 subscribers
Get Started
Global PR service
Reach Your Target
Audience in 160 Countries
powered by
Get Started
News by region
Korea
Overseas
News by industry
Health
Economy
Education
Finance
Technology
Life Style
Leisure
Culture & Entertainment
Transportation
Society
Heavy Industries
Environment
Government
Notice